Stock 300149 CHEMPARTNER PHARMATECH CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company ChemPartner PharmaTech Co.,Ltd.

Equities

300149

CNE100000Y27

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 16/07/2024 am IST 		5-day change 1st Jan Change
3.92 CNY -0.25% Intraday chart for ChemPartner PharmaTech Co.,Ltd. +1.55% -48.76%
24/06 ChemPartner PharmaTech Co.,Ltd.(XSEC:300149) dropped from S&P Global BMI Index CI
25/04 Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

ChemPartner PharmaTech Co Ltd, formerly Quantum Hi-tech China Biological Co Ltd, is a China-based company principally engaged in the research, development, production, and sales of fructooligosaccharides and other prebiotics. The Company's main products include fructooligosaccharides and galactooligosaccharides. The Company owns brands names of FOS and GOS. The Company's products are mainly used in nutrition and health products, dairy products, beverages, baked goods, functional candy and snack foods. The Company distributes its products mainly in domestic market, with South China as its main market.

Number of employees: 1,916

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical Research and Development and Production Outsourcing
99.5 %
1,191 89.8 % 1,133 99.5 % -4.92%
Headquarters and Industrial Funds
0.3 %
4 0.3 % 4 0.3 % -9.80%
Microecological Nutrition and Medical
0.3 %
137 10.3 % 4 0.3 % -97.33%
Adjustment and Eliminations
-0.2 %
-6 -0.5 % -2 -0.2 % -70.24%

Sales per region

CNY in Million2022Weight2023Weight Delta
United States
71.4 %
785 59.2 % 813 71.4 % +3.55%
China
17.3 %
392 29.5 % 197 17.3 % -49.83%
Other Countries or Regions
11.3 %
149 11.3 % 129 11.3 % -13.87%

Managers

Managers TitleAgeSince
Ji Guo Zhang CEO
 Chief Executive Officer 51 08/23/08
Yin Qun Cha DFI
 Director of Finance/CFO 45 08/23/08
Hong Hui Li IRC
 Investor Relations Contact - -
Jian Xu SEC
 Corporate Secretary 40 08/22/08
Wang Long Chen PRN
 Corporate Officer/Principal 52 01/21/01

Members of the board

Members of the board TitleAgeSince
Xin Hui BRD
 Director/Board Member 53 01/18/01
Zhi Cheng Guo BRD
 Director/Board Member 62 12/20/12
Xian Zhong Wang BRD
 Director/Board Member 54 23/21/23
Jia Hui Qi BRD
 Director/Board Member 51 01/18/01
Ji Guo Zhang CEO
 Chief Executive Officer 51 08/23/08
Da Chao Zhang CHM
 Chairman 50 24/21/24
Wang Long Chen PRN
 Corporate Officer/Principal 52 01/21/01
Shi Xin Fan BRD
 Director/Board Member 59 17/21/17
Ling Yang BRD
 Director/Board Member 63 30/23/30
Wen Ya Wang BRD
 Director/Board Member 41 31/23/31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 499,776,892 279,120,037 ( 55.85 %) 1,812,900 ( 0.3627 %) 55.85 %

Shareholders

NameEquities%Valuation
Shanghai Ruiyun Enterprise Management Center LP
6.891 %
34,380,629 6.891 % 19 M ¥
Rongtong Fund Management Co., Ltd.
0.5304 %
2,646,200 0.5304 % 1 M ¥
Wanjia Asset Management Co., Ltd.
0.1631 %
813,500 0.1631 % 443 358 ¥
Beixin Ruifeng Fund Management Co., Ltd.
0.1072 %
535,000 0.1072 % 291 575 ¥
HFT Investment Management Co., Ltd.
0.0484 %
241,448 0.0484 % 131 589 ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
0.0416 %
207,700 0.0416 % 113 197 ¥
Tebon Fund Management Co. Ltd.
0.0149 %
74,500 0.0149 % 40 603 ¥
Tian Hong Asset Management Co., Ltd.
0.0144 %
72,000 0.0144 % 39 240 ¥
Fullgoal Fund Management Co., Ltd.
0.0104 %
51,904 0.0104 % 28 288 ¥
Gfund Management Co., Ltd.
0.008278 %
41,300 0.008278 % 22 509 ¥

Company contact information

ChemPartner PharmaTech Co., Ltd.

28 F, Exchange Plaza 268 Dongfeng Middle Road

510031, Guangzhou

+

http://www.cppt.com.cn
address ChemPartner PharmaTech Co.,Ltd.(300149)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
CHEMPARTNER PHARMATECH CO.,LTD. Stock ChemPartner PharmaTech Co.,Ltd.
-48.76% 270M
MODERNA, INC. Stock Moderna, Inc.
+26.33% 46.56B
LONZA GROUP AG Stock Lonza Group AG
+45.38% 41.67B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.03% 41.16B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+32.94% 32.4B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+20.78% 28.18B
CELLTRION, INC. Stock Celltrion, Inc.
-6.35% 28.1B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+48.97% 14.52B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+48.08% 13.74B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+3.27% 12.17B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 300149 Stock
  4. Company ChemPartner PharmaTech Co.,Ltd.